Understanding the Role of Quality by Design in Chromatographic Method Development
Poster May 05, 2011
Michael McBrien, Juan Wang, Teresa Ponzio and Tara Sinclair
At the heart of QbD lies several principles, all leading toward the goal of building in quality from the earliest stages of drug development including knowledge retention, elimination of errors, and increased experimental scope. To be successful, QbD must be applied at every stage in the development and manufacturing process; however, one can consider processes within drug development on an individual basis to apply QbD principles.
One such process is the development of chromatographic methods for impurities and degradant studies. Ensuring both robustness and optimization from an efficiency standpoint is time-consuming and difficult. Generally, method development is carried out using a trial-and-error approach, and requires a large amount of manual data interpretation. However, QbD principles can be directly applied to this process resulting in better, more robust separations.
Automating Mass Spectrometry-Based Quantitative Glycomics using Tandem Mass Tag (TMT) Reagents with SimGlycanPoster
One of the emerging trends in glycomics research is the innovation related to accurate MS based quantitative analysis of glycans.READ MORE
RAMclust/RAMsearch: efficient post-XCMS feature clustering and annotation of MS-based metabolomics datasetsPoster
Chromatographically coupled mass spectrometry is a powerful tool for profiling, semi-quantitatively or quantitatively, a breadth of small molecules with sensitivity and selectivity.READ MORE
Highly Accurate HCV Genotyping by Targeted Next Generation SequencingPoster
The recent fast advancement of next generation sequencing (NGS) technologies allowing for unprecedented speed and accuracy in analyzing viral genomes are opening new ways to further improve diagnostic genotyping of HCV.